Frontiers | Performance of biomarkers NF-L, NSE, Tau and GFAP in blood and cerebrospinal fluid in...
Background: Target organ toxicity is often a reason for attritions in nonclinical and clinical drug development. Leveraging emerging safety biomarkers in non...
frontiersin.org